Statin use and female reproductive organ cancer risk in a large population-based setting

Statin use and female reproductive organ cancer ri...[Cancer Causes Control. 2008] - PubMed Result

Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA 1/2 associated ovarian carcinomas

Genome-Wide Loss of Heterozygosity and Uniparental...[Clin Cancer Res. 2008] - PubMed Result

Maintenance Treatment with Bevacizumab Prolongs Survival in and In vivo Ovarian Cancer model

Maintenance Treatment with Bevacizumab Prolongs Su...[Clin Cancer Res. 2008] - PubMed Result

Ovarian Cancer National Alliance - Regulatory - FDA HE4

Ovarian Cancer National Alliance - Regulatory - FDA HE4

"Our survey showed that most women are unaware of ovarian cancer symptoms......Survey results show that 50 percent of the respondents did not know about the specialty of gynecologic oncologists. Furthermore, 48 percent of the respondents reported that the doctors they contacted to evaluate symptoms did not refer them to gynecologic oncologists...."

The Cochrane Collaboration - Cochrane News and other newsletters/information sources

The Cochrane Collaboration - Cochrane News and other newsletters

Time to stop ovarian cancer screening in BRCA 1/2 mutation carriers?

HighWire Press -- Medline Abstract

"Annual gynecological screening of women with a BRCA1/2 mutation to prevent advanced stage ovarian cancer is not effective."

Cancer in Canada in 2008 -- Marrett et al. 179 (11): 1163 -- Canadian Medical Association Journal

Cancer in Canada in 2008 -- Marrett et al. 179 (11): 1163 -- Canadian Medical Association Journal